Cellceutix Corporation to Present at Upcoming Conferences

BEVERLY, MA–(Marketwired – September 07, 2016) - Cellceutix Corporation (OTC: CTIX) (“the Company”), a clinical stage biopharmaceutical company developing innovative therapies with oncology, dermatology, antibiotic, and anti-inflammatory applications, today announces that management will present at two upcoming conferences highlighting the continuing advancement of the Company’s clinical programs.

  • Friday, September 9, 2016 – Cellceutix will present at the 23rd Annual Newsmakers in the Biotech Industry Conference in New York City at 8:30 am ET. This presentation will be made available in the Investors section of the cellceutix.com website.
  • Monday, September 19, 2016 – Cellceutix will present, and participate in multiple panel discussions, at the 14th Annual Discovery on Target Conference in Boston. The Company’s main presentation is titled, “Prurisol: A New Small Molecule under investigation for the treatment of Psoriasis,” and will be made available in the Investors section of the cellceutix.com website.